Medtronic plc (mdt)
MDT Estimates
Public analyst price targets and consensus snapshot for Medtronic plc. Deeper estimate history and models are available in Vest Terminal.
| Last price | $89.30 |
| Analyst mean target | $104.83 |
| Analyst high target | $121.00 |
| Analyst low target | $85.00 |
| Upside vs mean target | 17.4% |
| Consensus recommendation | Buy |
| Number of analysts | 24 |
| Forward P/E | 13.94 |
Start Free — open MDT in Vest Terminal
Access live data, filings, ownership, and analysis for Medtronic plc.
Medtronic plc FAQ
What does Medtronic plc (MDT) do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio…
What is MDT's P/E ratio?
Medtronic plc has a trailing P/E of 22.38× based on publicly available market data.
Does MDT pay a dividend?
Indicated dividend yield: 3.2%. Confirm ex-dates and payout history in Vest Terminal.
What sector is MDT in?
Medtronic plc is classified in Healthcare (Medical Devices) on NYQ.
What is MDT's market capitalization?
Approximate market cap: $114.23B.
What are the main risks for MDT?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of MDT?
Potential positives include revenue growth of 13.7% year-over-year, earnings growth of 40.7% year-over-year.
Where can I get analyst estimates for MDT?
Public analyst price targets and consensus for Medtronic plc are on the free /stocks/mdt/estimates page. Deeper estimate history and models are available in Vest Terminal.